✦ LIBER ✦

Once versus three times daily dosing of oral budesonide for active Crohn's disease: A double-blind, double-dummy, randomised trial

✍ Scribed by Dignass, Axel; Stoynov, Simeon; Dorofeyev, Andrey E.; Grigorieva, Galina A.; Tomsová, Eva; Altorjay, István; Tuculanu, Daniel; Bunganič, Ivan; Pokrotnieks, Juris; Kupčinskas, Limas; Dilger, Karin; Greinwald, Roland; Mueller, Ralph

Book ID: 122137083
Publisher: Oxford University Press
Year: 2014
Tongue: English
Weight: 706 KB
Volume: 8
Category: Article
ISSN: 1873-9946
DOI: 10.1016/j.crohns.2014.01.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P606 Once-daily versus three-times-daily

P606 Once-daily versus three-times-daily oral budesonide in active Crohn's disease: a double-blind, double-dummy, randomized trial

✍ Dignass, A.; Grinevich, V.; Zakharash, M.; Goldis, A.; Jonaitis, L.; Gabalec, L. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 97 KB

Sa1217 Once Daily Dosing of 9mg Budesoni

Sa1217 Once Daily Dosing of 9mg Budesonide (Budenofalk®) Is Therapeutic Equivalent to a Three-Times Daily Dosing of 3mg Budesonide for the Treatment of Active Crohn's Disease: A Randomized, Double-Blind, Double-Dummy, Multicenter Phase III Study

✍ Dignass, Axel U.; Stoynov, Simeon; Dorofeyev, Andrey E.; Grigorieva, Galina A.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 414 KB

Budesonide (BUD) versus prednisone (pred

Budesonide (BUD) versus prednisone (pred) in the treatment of active Crohn's disease (CD): A double-blind controlled trial

✍ Bar-Meir, S. 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 176 KB

83 Efficacy and Tolerability of a Once D

83 Efficacy and Tolerability of a Once Daily Treatment with Budesonide Capsules Versus Mesalamine Granules for the Treatment of Active Ulcerative Colitis: A Randomized, Double-Blind, Double-Dummy, Multicenter Study

✍ Volker Gross; Ivan Bunganic; Tatyana L. Mikhailova; Limas Kupcinskas; Gediminas 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 71 KB

A randomised double blind controlled tri

A randomised double blind controlled trial of high versus low long chain triglyceride whole protein feed in active Crohn's disease

✍ Leiper, Keith; Woolner, Jenny T.; Parker, Tracy J.; van der Vleit, Martine; Mull 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 188 KB

P608 Azathioprine versus mesalazine for

P608 Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in Crohn's disease patients with endoscopic recurrence: follow-up data of a randomised, double-blind, double-dummy, 1-year, multicentre trial

✍ Reinisch, W.; Angelberger, S.; Petritsch, W.; Shonova, O.; Lukas, M.; Greinwald, 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 97 KB